This test is most useful if any of these apply to you.
Cortisol usually falls around your usual bedtime and rises again before you wake. An overnight urine sample can describe part of that pattern, but cortisone also reflects how your tissues process cortisol. A single mid-sleep result can't establish why you wake at night or whether you have a hormone disorder. Research on daily steroid rhythms, urinary cortisone research.
This specific timepoint is an exploratory measurement. Published studies support measuring cortisone in urine, but they haven't established that using U0 results to guide care improves sleep, prevents diabetes, or reduces heart disease. There is no validated U0 treatment target for those outcomes. Dried-urine validation study.
Cortisol is a hormone made by the adrenal glands above your kidneys. It helps regulate blood sugar and the response to stress. Your kidneys convert some cortisol into inactive cortisone, while other tissues can convert cortisone back into cortisol. Urinary cortisone therefore depends on both hormone production and conversion. Human studies of cortisol and cortisone conversion.
In DUTCH reporting, U0 identifies the optional mid-sleep urine sample. Cortisone is reported relative to urine creatinine in ng/mg. Creatinine is a waste product used to account for urine concentration. This adjustment reduces the influence of dilution. DUTCH report documentation, urine validation study.
Urine contains hormone excreted over the interval since your previous urination. Your result therefore represents an interval, not the cortisol concentration in your blood at the moment you collect it. Someone collecting shortly after midnight and someone collecting close to morning may capture different parts of the daily rise and fall. DUTCH overnight collection explanation.
In 214 healthy volunteers, repeated samples of fluid beneath the skin showed daily rhythms in both cortisol and cortisone. That study measured tissue fluid. It supports the underlying biology, but it doesn't establish how accurately a U0 urine value captures your circulating cortisol or its lowest point. Upton et al..
A study in 28 people found good agreement between combined four-spot dried-urine measurements and complete 24-hour collections. It didn't establish the diagnostic accuracy of an isolated mid-sleep sample. The authors were affiliated with the laboratory that developed the test. Newman et al..
Cushing's syndrome results from prolonged excess exposure to cortisol or related steroid medicines. When your body produces excess cortisol, the usual nighttime fall can disappear. Late-night salivary cortisol is an established screening test in suitable circumstances; mid-sleep urinary cortisone hasn't been validated as an interchangeable substitute. Endocrine Society diagnostic guideline.
Some adrenal nodules release cortisol independently of the body's usual control signals without causing the full features of Cushing's syndrome. This is called mild autonomous cortisol secretion. A study compared 72 people with this condition with 72 matched controls. Separate daytime and nighttime urine collections showed a larger share of steroid excretion occurring at night in the affected group. The researchers measured a panel of steroids over timed collection periods, so the finding doesn't validate an individual U0 cortisone result. Saini et al..
The condition matters clinically. In an international cohort of 3,656 people with adrenal nodules, autonomous cortisol secretion was associated with higher mortality. The excess risk was largest in women younger than 65 and more modest across the group as a whole. Cortisol secretion was classified using blood cortisol after dexamethasone suppression. The study didn't assess risk from mid-sleep urine cortisone. Deutschbein et al.00100-0).
Cortisone in saliva has also been studied after dexamethasone suppression. In 173 people with adrenal nodules, it closely tracked the accompanying blood cortisol result. This was a comparison with a blood-test endpoint after medication, not a test of whether untreated mid-sleep urine cortisone detects a cortisol-secreting nodule. Issa et al..
The long-term outcome studies used other cortisol measurements. They provide reasons to study hormone timing, but they don't provide a way to calculate your cardiovascular risk from U0 cortisone.
| Who Was Studied | What Was Measured | What They Found |
|---|---|---|
| About 4,000 British civil servants | Salivary cortisol across the day | A flatter decline and higher bedtime cortisol were associated with cardiovascular death. Waking cortisol and the awakening response weren't associated with mortality. Whitehall II. |
| 861 older adults followed for six years | Cortisol in complete 24-hour urine collections | Higher excretion was associated with cardiovascular death. This was cortisol collected across a full day. Vogelzangs et al.. |
| 250 people undergoing coronary bypass surgery | Salivary cortisol before surgery | A flatter daily decline was associated with subsequent cardiac events or death. Ronaldson et al.. |
| Prospective population cohorts and genetic analyses | Morning plasma cortisol | Higher morning cortisol was associated with cardiovascular disease. The genetic analysis was compatible with a causal contribution but remained inconclusive. Crawford et al.. |
A study of 191 men found that lower daytime salivary cortisol activity predicted later changes in blood markers related to clotting and inflammation. It did not show that lower cortisol predicted more heart attacks. These different measurements and endpoints can't be combined into a rule that a particular nighttime cortisone value is safer. Degroote et al..
Excess cortisol can make blood sugar harder to control. In the CATALYST study, about one quarter of 1,057 people with difficult-to-control type 2 diabetes met the study's definition of hypercortisolism. That definition relied on inadequate suppression of blood cortisol after dexamethasone, with adequate dexamethasone exposure confirmed. It wasn't based on urine cortisone. Buse et al..
The participants were a selected group taking multiple diabetes medicines. The proportion doesn't apply to everyone with diabetes, and an abnormal suppression result alone doesn't establish that excess cortisol caused someone's poor glucose control. Corcept Therapeutics funded the study. Its findings support considering a targeted cortisol evaluation in this setting; they don't establish a role for U0 screening. CATALYST study.
Sleep disruption can change cortisol patterns. In an experiment involving 22 young women, fragmented sleep raised bedtime blood cortisol and reduced the rise after waking. A subset repeated the experiment after estrogen suppression, which lowered bedtime cortisol. These were blood measurements in an experimental model of menopause, so they don't establish the direction of a change in mid-sleep urine cortisone. Cohn et al..
Among 301 nurses, irregular shifts and certain sleep characteristics were associated with lower cortisol in first-morning urine collected on a nonworkday. The study didn't measure a complete overnight rhythm or U0 cortisone. It also doesn't show that longer sleep causes hormone dysfunction. Li et al..
Cortisol activity is normally low during part of the night, but a low urine cortisone result can't establish whether your adrenal glands can produce enough cortisol when needed. Urinary steroid values overlap between healthy people and people with adrenal insufficiency. Even combining low nighttime and waking urine results doesn't establish that diagnosis. Mayo Clinic Laboratories.
Research on a home waking salivary cortisone sample has shown promise for screening for adrenal insufficiency. Both the specimen and timing differ from this test, so that finding can't be transferred to mid-sleep urine. Debono et al..
One referral-center study found that about one in five people taking inhaled steroid medicines without other steroid treatment had an abnormal adrenal stimulation test. That was a selected group who had undergone testing, not an estimate for typical inhaler users. Rates are higher with high doses and long-term use, and pooled estimates across all inhaled-steroid users are considerably lower. The study measured blood cortisol responses, not U0 cortisone. Woods et al., Glucocorticoid guideline.
Salivary cortisol and cortisone vary from day to day, but those studies don't establish how many U0 urine samples are needed to define a stable personal pattern. Repeated U0 results may describe changes under similar collection conditions. They haven't been shown to detect disease earlier or to prove that a change in sleep or treatment improved your health. Salivary biological-variation study.
Cortisone (U0 Mid-Sleep) is best interpreted alongside these tests.
Cortisone (U0 Mid-Sleep) is included in these pre-built panels.
An at-home dried-urine panel that maps sex and adrenal hormones plus metabolites, cortisol rhythms, melatonin, and markers of nutrient/oxidative-stress status.